ACOR logo

Acorda Therapeutics (ACOR) Selling, General & Administrative Expenses

Annual SGA

$89.70 M
-$16.56 M-15.58%

December 31, 2023

Summary

Performance

1-Year Change

-15.58%

3-Year Change

-41.21%

5-Year Change

-47.93%

15-Year Change

-50.61%

ACOR SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$235.44 M
ACOR annual SGA is currently -61.90% below its historical high of $235.44 million

3-Year Low

$89.70 M
ACOR annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ACOR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ACOR next annual earnings announcement has not yet been scheduled

OtherACORexpensesmetrics:

Annual Total Expenses

$140.90 M
ACOR annual total expenses is $140.90 million

Annual Operating Expenses

$125.61 M
ACOR annual total operating expenses is $125.61 million

Annual Cost Of Goods Sold

$15.28 M
ACOR annual cost of goods sold is $15.28 million

Annual Interest Expense

$31.53 M
ACOR annual interest expense is $31.53 million

Quarterly SGA

$28.37 M
+$6.17 M+27.76%

March 31, 2024

Summary

Performance

3-Month Change

+27.76%

1-Year Change

+26.01%

3-Year Change

-16.48%

5-Year Change

-46.19%

ACOR Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$62.60 M
ACOR quarterly SGA is currently -54.68% below its historical high of $62.60 million

3-Year Low

$21.82 M
ACOR quarterly SGA is currently +29.99% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
ACOR previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
ACOR next earnings announcement has not yet been scheduled

OtherACORexpensesmetrics:

Quarterly Total Expenses

$33.68 M
ACOR quarterly total expenses is $33.68 million

Quarterly Operating Expenses

$29.97 M
ACOR quarterly total operating expenses is $29.97 million

Quarterly Cost Of Goods Sold

$3.71 M
ACOR quarterly cost of goods sold is $3.71 million

Quarterly Interest Expense

$8.06 M
ACOR quarterly interest expense is $8.06 million

TTM SGA

-$4.34 B
-$263.43 M-6.46%

March 31, 2024

Summary

Performance

3-Month Change

-4937.95%

1-Year Change

-4361.42%

3-Year Change

-3083.8%

5-Year Change

-2350.24%

ACOR TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$114.28 M

3-Year Low

-$4.34 B
ACOR TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
ACOR previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
ACOR next earnings announcement has not yet been scheduled

OtherACORexpensesmetrics:

Annual Total Expenses

$140.90 M
ACOR annual total expenses is $140.90 million

Annual Operating Expenses

$125.61 M
ACOR annual total operating expenses is $125.61 million

TTM Cost Of Goods Sold

$15.76 M
ACOR TTM cost of goods sold is $15.76 million

TTM Interest Expense

$32.67 M
ACOR TTM interest expense is $32.67 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$89.70 M
ACOR annual SGA is $89.70 million

Annual Operating Expenses

$125.61 M
ACOR annual total operating expenses is $125.61 million

Annual Cost Of Goods Sold

$15.28 M
ACOR annual cost of goods sold is $15.28 million

ACOR Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-15.6%+26.0%-4361.4%
3 y3 years-41.2%-16.5%-3083.8%
5 y5 years-47.9%-46.2%-2350.2%

ACOR Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-27.9%at low-5.6%-23.1%+29.8%at low
5 y5-year-53.5%at low-31.2%-23.1%+87.9%at low
alltimeall time-61.9%-100.0%-54.7%-80.5%+3697.2%at low

Acorda Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Mar 2024
-
$28.37 M(+27.8%)
$95.55 M(+6.5%)
Dec 2023
$89.70 M(-15.6%)
$22.21 M(-4.1%)
$89.70 M(-4.3%)
Sep 2023
-
$23.15 M(+6.1%)
$93.75 M(+0.2%)
Jun 2023
-
$21.82 M(-3.1%)
$93.59 M(-8.1%)
Mar 2023
-
$22.51 M(-14.2%)
$101.83 M(-4.2%)
Dec 2022
$106.26 M(-14.6%)
$26.25 M(+14.2%)
$106.26 M(-2.0%)
Sep 2022
-
$23.00 M(-23.5%)
$108.44 M(-5.8%)
Jun 2022
-
$30.07 M(+11.6%)
$115.07 M(-2.0%)
Mar 2022
-
$26.94 M(-5.3%)
$117.37 M(-5.7%)
Dec 2021
$124.40 M(-18.5%)
$28.44 M(-4.0%)
$124.40 M(-3.4%)
Sep 2021
-
$29.62 M(-8.5%)
$128.84 M(-7.4%)
Jun 2021
-
$32.37 M(-4.7%)
$139.15 M(-4.3%)
Mar 2021
-
$33.97 M(+3.3%)
$145.44 M(-4.7%)
Dec 2020
$152.58 M(-20.9%)
$32.88 M(-17.7%)
$152.57 M(-5.2%)
Sep 2020
-
$39.94 M(+3.3%)
$160.92 M(-5.2%)
Jun 2020
-
$38.66 M(-6.0%)
$169.69 M(-6.4%)
Mar 2020
-
$41.11 M(-0.3%)
$181.23 M(-6.0%)
Dec 2019
$192.85 M(+12.0%)
$41.22 M(-15.4%)
$192.85 M(+2.3%)
Sep 2019
-
$48.70 M(-3.0%)
$188.44 M(+2.8%)
Jun 2019
-
$50.20 M(-4.8%)
$183.31 M(+3.3%)
Mar 2019
-
$52.73 M(+43.2%)
$177.38 M(+3.0%)
Dec 2018
$172.25 M(-5.2%)
$36.82 M(-15.5%)
$172.25 M(-1.5%)
Sep 2018
-
$43.57 M(-1.6%)
$174.95 M(+1.6%)
Jun 2018
-
$44.26 M(-7.0%)
$172.12 M(-2.9%)
Mar 2018
-
$47.60 M(+20.5%)
$177.19 M(-2.4%)
Dec 2017
$181.62 M(-22.9%)
$39.52 M(-3.0%)
$181.62 M(-9.7%)
Sep 2017
-
$40.74 M(-17.4%)
$201.15 M(-6.5%)
Jun 2017
-
$49.33 M(-5.2%)
$215.21 M(-5.8%)
Mar 2017
-
$52.02 M(-11.9%)
$228.48 M(-3.0%)
Dec 2016
$235.44 M(+14.5%)
$59.05 M(+7.7%)
$235.44 M(+2.6%)
Sep 2016
-
$54.80 M(-12.5%)
$229.37 M(+1.7%)
Jun 2016
-
$62.60 M(+6.1%)
$225.63 M(+4.5%)
Mar 2016
-
$58.98 M(+11.3%)
$215.84 M(+5.0%)
Dec 2015
$205.63 M(+1.9%)
$52.98 M(+3.8%)
$205.63 M(-1.7%)
Sep 2015
-
$51.06 M(-3.3%)
$209.10 M(+1.6%)
Jun 2015
-
$52.82 M(+8.3%)
$205.86 M(+1.1%)
Mar 2015
-
$48.77 M(-13.6%)
$203.69 M(+0.9%)
Dec 2014
$201.81 M
$56.46 M(+18.1%)
$201.81 M(+4.9%)
Sep 2014
-
$47.82 M(-5.6%)
$192.36 M(+2.9%)
DateAnnualQuarterlyTTM
Jun 2014
-
$50.64 M(+8.0%)
$186.88 M(+1.4%)
Mar 2014
-
$46.89 M(-0.2%)
$184.24 M(-0.7%)
Dec 2013
$185.54 M(+10.0%)
$47.01 M(+11.0%)
$185.54 M(+0.8%)
Sep 2013
-
$42.34 M(-11.8%)
$184.13 M(+1.2%)
Jun 2013
-
$48.00 M(-0.4%)
$181.92 M(+2.1%)
Mar 2013
-
$48.20 M(+5.7%)
$178.14 M(+5.6%)
Dec 2012
$168.69 M(+13.6%)
$45.59 M(+13.6%)
$168.69 M(+6.2%)
Sep 2012
-
$40.12 M(-9.3%)
$158.82 M(+3.5%)
Jun 2012
-
$44.23 M(+14.2%)
$153.41 M(+2.7%)
Mar 2012
-
$38.74 M(+8.5%)
$149.32 M(+0.6%)
Dec 2011
$148.51 M(+11.9%)
$35.72 M(+2.9%)
$148.51 M(-3.8%)
Sep 2011
-
$34.72 M(-13.5%)
$154.39 M(+2.8%)
Jun 2011
-
$40.14 M(+5.8%)
$150.23 M(+4.2%)
Mar 2011
-
$37.93 M(-8.8%)
$144.20 M(+8.4%)
Dec 2010
$132.66 M(+47.0%)
$41.60 M(+36.1%)
$132.99 M(+16.4%)
Sep 2010
-
$30.56 M(-10.4%)
$114.28 M(+6.7%)
Jun 2010
-
$34.11 M(+27.7%)
$107.14 M(+10.5%)
Mar 2010
-
$26.71 M(+16.7%)
$96.95 M(+7.4%)
Dec 2009
$90.26 M(+23.1%)
$22.90 M(-2.2%)
$90.26 M(+3.8%)
Sep 2009
-
$23.42 M(-2.1%)
$86.93 M(+3.6%)
Jun 2009
-
$23.93 M(+19.5%)
$83.88 M(+8.2%)
Mar 2009
-
$20.02 M(+2.3%)
$77.53 M(+6.5%)
Dec 2008
$73.31 M(+52.2%)
$19.57 M(-3.9%)
$72.76 M(+8.9%)
Sep 2008
-
$20.37 M(+15.9%)
$66.81 M(+15.0%)
Jun 2008
-
$17.57 M(+15.1%)
$58.08 M(+11.5%)
Mar 2008
-
$15.26 M(+12.1%)
$52.10 M(+8.2%)
Dec 2007
$48.17 M(+52.2%)
$13.61 M(+17.0%)
$48.17 M(+12.6%)
Sep 2007
-
$11.64 M(+0.4%)
$42.78 M(+7.3%)
Jun 2007
-
$11.59 M(+2.4%)
$39.88 M(+10.4%)
Mar 2007
-
$11.32 M(+37.7%)
$36.12 M(+14.2%)
Dec 2006
$31.64 M(+46.9%)
$8.22 M(-5.8%)
$31.64 M(+9.3%)
Sep 2006
-
$8.73 M(+11.3%)
$28.95 M(+7.6%)
Jun 2006
-
$7.84 M(+14.7%)
$26.91 M(+41.1%)
Mar 2006
-
$6.84 M(+23.5%)
$19.07 M(+55.9%)
Dec 2005
$21.53 M(+20.0%)
$5.54 M(-17.3%)
$12.23 M(+82.7%)
Sep 2005
-
$6.69 M(-38.0%)
$6.69 M(-38.0%)
Dec 2004
$17.95 M(>+9900.0%)
-
-
Dec 2003
$0.00(-100.0%)
-
-
Sep 2003
-
$10.80 M
$10.80 M
Jun 2003
$6.39 M
-
-

FAQ

  • What is Acorda Therapeutics annual SGA?
  • What is the all time high annual SGA for Acorda Therapeutics?
  • What is Acorda Therapeutics annual SGA year-on-year change?
  • What is Acorda Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Acorda Therapeutics?
  • What is Acorda Therapeutics quarterly SGA year-on-year change?
  • What is Acorda Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Acorda Therapeutics?
  • What is Acorda Therapeutics TTM SGA year-on-year change?

What is Acorda Therapeutics annual SGA?

The current annual SGA of ACOR is $89.70 M

What is the all time high annual SGA for Acorda Therapeutics?

Acorda Therapeutics all-time high annual SGA is $235.44 M

What is Acorda Therapeutics annual SGA year-on-year change?

Over the past year, ACOR annual SGA has changed by -$16.56 M (-15.58%)

What is Acorda Therapeutics quarterly SGA?

The current quarterly SGA of ACOR is $28.37 M

What is the all time high quarterly SGA for Acorda Therapeutics?

Acorda Therapeutics all-time high quarterly SGA is $62.60 M

What is Acorda Therapeutics quarterly SGA year-on-year change?

Over the past year, ACOR quarterly SGA has changed by +$5.86 M (+26.01%)

What is Acorda Therapeutics TTM SGA?

The current TTM SGA of ACOR is -$4.34 B

What is the all time high TTM SGA for Acorda Therapeutics?

Acorda Therapeutics all-time high TTM SGA is -$114.28 M

What is Acorda Therapeutics TTM SGA year-on-year change?

Over the past year, ACOR TTM SGA has changed by -$4.44 B (-4361.42%)